BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2992120)

  • 1. Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver.
    Gaeta GB; Utili R; Adinolfi LE; Abernathy CO; Giusti G
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):185-92. PubMed ID: 2992120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alterations in liver function produced by erythromycin estolate in isolated and perfused rat liver].
    Adinolfi L; Gaeta GB; Utili R
    Boll Soc Ital Biol Sper; 1980 Aug; 56(16):1621-5. PubMed ID: 7459082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin.
    Gaeta GB; Adinolfi LE; Utili R; Tripodi MF; Abernathy CO
    Life Sci; 1986 Aug; 39(5):453-60. PubMed ID: 3526067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis].
    Adinolfi L; Perna P; Gaeta GB; Utili R
    Boll Soc Ital Biol Sper; 1981 Apr; 57(8):900-3. PubMed ID: 7023509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic doses of erythromycin esteolate is not cholestatic in rats in vivo.
    Fiebiger I; Anwer MS; Hegner D
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):295-7. PubMed ID: 6866136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chlorpromazine and erythromycin on bile salt-induced cholestasis in the rat.
    Drew R; Piestly BG
    Pharmacology; 1979; 18(4):202-9. PubMed ID: 572556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of in vivo treatment with a new fluorinated macrolide (P-0501A) and other erythromycins on drug clearance and hepatic functions in perfused rat liver.
    Villa P; Corti F; Guaitani A; Bartosek I; Casacci F; De Marchi F; Pacei E
    J Antibiot (Tokyo); 1986 Jun; 39(6):839-45. PubMed ID: 3733532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by S-adenosyl-L-methionine of hepatic Na+,K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis.
    Boelsterli UA; Rakhit G; Balazs T
    Hepatology; 1983; 3(1):12-7. PubMed ID: 6295906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furosemide choleresis in isolated perfused rat liver: partial dependency on perfusate sodium and chloride.
    Anwer MS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):313-8. PubMed ID: 2997429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity.
    Miccio M; Orzes N; Lunazzi GC; Gazzin B; Corsi R; Tiribelli C
    Biochem Pharmacol; 1989 Oct; 38(20):3559-63. PubMed ID: 2554925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chlorpromazine on hepatic perfusion and bile secretory function in the isolated perfused rat liver.
    Tavoloni N; Reed JS; Hruban Z; Boyer JL
    J Lab Clin Med; 1979 Nov; 94(5):726-41. PubMed ID: 227976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450.
    Amacher DE; Schomaker SJ; Retsema JA
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1186-90. PubMed ID: 1656856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
    Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
    Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole impairs biliary excretory function in the isolated perfused rat liver.
    Gaeta GB; Tripodi MF
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):697-700. PubMed ID: 3627286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromycin toxicity in primary cultures of rat hepatocytes.
    Villa P; Bégué JM; Guillouzo A
    Xenobiotica; 1985; 15(8-9):767-73. PubMed ID: 4072263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amphotericin B on the excretory function and the colloid clearance capacity of the perfused rat liver.
    Gaeta GB; Utili R; Adinolfi LE; Tripodi MF; Esposito V
    J Hepatol; 1989 May; 8(3):344-50. PubMed ID: 2732448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat.
    Accatino L; Contreras A; Berdichevsky E; Quintana C
    J Lab Clin Med; 1981 Apr; 97(4):525-34. PubMed ID: 6259265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha-asarone and a derivative on lipids, bile flow and Na+/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat.
    Garduño-Siciliano L; Labarrios F; Tamariz J; Moreno MG; Chamorro G; Muriel P
    Fundam Clin Pharmacol; 2007 Feb; 21(1):81-8. PubMed ID: 17227448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete biliary obstruction due to erythromycin estolate administration in an infant.
    Krowchuk D; Seashore JH
    Pediatrics; 1979 Dec; 64(6):956-8. PubMed ID: 514726
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity.
    Richelmi P; Baldi C; Manzo L; Berte F; Martino AP; Mirabelli F; Bellomo G
    Arch Toxicol Suppl; 1984; 7():298-302. PubMed ID: 6595996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.